Four patients (4.1%) underwent concomitant secondary major amputation during the same hospitalization. Median hospital length of stay was 8 days. Half of those patients were discharged home, while the rest were discharged to a skilled nursing facility or a rehabilitation center (23.7%), transferred to a general hospital (5.2%), or home under home health service organization (13.4%). The median cost of hospitalization for these patients was $21,291 (U.S.) with a median fixed and variable cost of $8960 (U.S.) each.
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Iliofemoral Endarterectomy and Iliac Stenting in TASC C/D Aortoiliac
Objectives: This study reports the outcomes of hybrid revascularization combining iliofemoral endarterectomy and iliac artery stenting using covered stents in TASC C and D aortoiliac occlusive disease involving femoral bifurcation.
Methods: A retrospective review was conducted of patients with TASC C and D aortoiliac occlusive disease undergoing hybrid revascularization between December 2009 and July 2016 at a single academic center. Demographics, indications for surgery, lesion classification and location, stent location and type, length of stay (LOS), 90-day morbidity and mortality, and patency were assessed. Primary outcomes were hemodynamic success (defined as an increase in the ipsilateral ankle-brachial index [ABI] of at least 0.1), clinical success (improved symptoms of claudication, rest pain, or wound healing) at 30 days, and patency. All patients underwent a preoperative and follow-up ABI and pulse volume recording (PVR).
Results: Thirty-six male patients, mean age 63.9 6 6.0 years, underwent revascularization of 41 limbs (TASC C: 39%; D: 61%). There were no significant differences in demographics, comorbidities, or indications between TASC C and D patients. Indications for surgery were claudication (27%), rest pain (44%), or tissue loss (29%). Mean operative time was 340 6 100 minutes with estimated blood loss 500 mL (275-1000 mL). Seventy-seven stents were placed (66 covered, 11 bare metal). Covered stents were used primarily, and bare-metal stents were used at the iliac bifurcation to preserve internal iliac artery patency. All external iliac arteries were treated with covered stents. Simultaneous adjunctive procedures (5 infrainguinal bypasses, 3 superficial femoral artery stents) were performed in 22%. Ninety-day complications included 1 pulmonary embolus, 1 pneumonia, 4 surgical-site infections, 2 hematomas, 3 seromas, 1 stent thrombosis, 1 femoral artery pseudoaneurysm, and 1 infected covered stent. Hospital and intensive care unit LOS were 4 days (3-6 days) and 2 days (2-3 days), respectively. All patients with available data experienced 30-day clinical and hemodynamic success. Mean follow-up was 23 months (range, 1-79 months) with a primary patency of 85.4%. Cumulative primary assisted and secondary patency was 92.6%. The femoral patch repair was the most frequent site of reintervention. Mortality was 34% overall during the study period with one death at 30 days. Conclusions: Hybrid approach has low morbidity and mortality and fast recovery. It is a safe, effective and lasting treatment for TASC C and D aortoiliac occlusive disease involving the femoral bifurcation. The use of covered stents provides good midterm patency. Close follow-up with noninvasive imaging is paramount to avoiding repair failure by diagnosing recurrent stenosis, in particular at the femoral patch repair site.
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Results: The National Surgical Quality Improvement Program database identified 6978 patients who underwent infrainguinal lower extremity arterial bypass during the study period. Of these, 6101 patients (87.4%) had mild-moderate CKD, 327 patients (4.7%) had severe CKD, and 550 patients (7.9%) were on HD. Patients with severe CKD and on HD were more likely to have revascularization for tissue loss (54.9% vs 68.8% and 74.7%; P < .01). Patients with severe CKD and those on HD had higher rates of graft failure, mortality, postoperative myocardial infarction (MI), and rates of reoperation (Table I) . Multivariable analysis confirmed these results, showing that HD was associated with postoperative MI, readmission, and increased mortality (Table II) . It also demonstrated that severe CKD was associated with graft failure (odds ratio [OR] 
